Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPC1 | O15118 | 1/20 | 0.37 |
| ▸ | KLKB1 | P03952 | 1/20 | 0.35 |
| ▸ | F11 | P03951 | 1/20 | 0.33 |
| ▸ | F2RL1 | P55085 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | ELANE | P08246 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5381357 | 0.87 | NPC1 (0.35) | NPC1KLKB1F2RL1 | |
| SCHEMBL5369563 | 0.80 | ELANE (0.42) | NPC1KLKB1F11MAPTELANE | |
| SCHEMBL4935109 | 0.74 | CASR (0.39) | NPC1ELANE | |
| SCHEMBL4935725 | 0.73 | MMP13 (0.40) | NPC1MAPT | |
| SCHEMBL4932747 | 0.73 | ELANE (0.43) | NPC1ELANE | |
| SCHEMBL4934889 | 0.70 | SMN1; SMN2 (0.38) | NPC1MAPT | |
| SCHEMBL30889616 | 0.70 | NPC1 (0.36) | NPC1KLKB1F11MAPT | |
| SCHEMBL3059529 | 0.70 | NPC1 (0.40) | NPC1KLKB1F11MAPT | |
| SCHEMBL1314051 | 0.69 | NPC1 (0.35) | NPC1KLKB1F11MAPT | |
| SCHEMBL1316068 | 0.69 | NPC1 (0.35) | NPC1KLKB1F11MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1740551-A1 | HETEROCYCLIC AMIDE COMPOUND AND USE THEREOF AS AN MMP-13 INHIBITOR | Takeda Pharmaceutical Company Limited (JP) | 2007-01-10 | — | — | EP | disclosed |
| WO-2005105760-A1 | HETEROCYCLIC AMIDE COMPOUND AND USE THEREOF AS AN MMP-13 INHIBITOR | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2005-11-10 | — | — | WO | disclosed |